Nycomed

Represented certain shareholders of Nycomed, a European pharmaceuticals company with a value of€1,800,000,000 and offices in 18 European markets, in connection with the acquisition by Nordic Capital of a controlling interest in Nycomed from a group of investors led by DLJ Merchant Banking and The Blackstone Group.